Outcome of Rituximab Therapy in Patients with Systemic Lupus Erythematosus

Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple organs. Rituximab (RTX) is an anti-CD20 monoclonal antibody that is an approved treatment for various autoimmune diseases. However, no randomized controlled trial (RCT) has proved the benefit of RTX for pa...

詳細記述

書誌詳細

出版年:	Annals of Rheumatology and Autoimmunity
主要な著者:	Mufaddal Adil Alaithan, Hussein Halabi, Maryam Mohammed Shamaa, Rawan Naser Alharbi, Nuwar Ibrahim Aljoma, Hanan Al Rayes
フォーマット:	論文
言語:	英語
出版事項:	Wolters Kluwer Medknow Publications 2023-01-01
主題:	lupus erythematosus lupus nephritis rituximab systemic
オンライン･アクセス:	https://journals.lww.com/10.4103/ara.ara_10_22